A Study on the Preference of Risperidone Dosage Forms
Recruiting
Observational Study
Schizophrenia
Bipolar Affective Disorder
Autism Spectrum Disorder
Conduct Disorder
Mental Retardation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Shanghai Mental Health Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.
Exclusion Criteria:
* Have difficulty reading and understanding Chinese or refuse to participate in the study.
Contacts